Eton Pharmaceuticals & Anovo Partner to Expand Access for Patients with Severe Primary Insulin-Like Growth Factor 1 Deficiency
January 23, 2025
Eton Pharmaceuticals is dedicated to developing and commercializing treatments for rare diseases, with a strong focus on pediatric endocrinology. Their commitment to addressing underserved conditions has led to the acquisition of INCRELEX®, the only FDA-approved therapy for children and adolescents aged 2 to 18 with severe primary insulin-like growth factor 1 deficiency (SPIGFD).
What is Severe Primary Insulin-Like Growth Factor 1 Deficiency?
SPIGFD is a rare and serious condition that impacts growth and development. Children with this condition don’t produce enough insulin-like growth factor 1 (IGF-1), a hormone essential for normal growth. This leads to severe growth failure, often with symptoms like short stature and developmental delays. While SPIGFD affects only about 200 children in the U.S., its impact on their lives is profound, making timely and effective treatment crucial.
Eton Pharmaceuticals Partners with Anovo
Anovo is proud to partner with Eton Pharmaceuticals as the exclusive distributor and specialty pharmacy for INCRELEX®. Through the Eton Cares program, we’re ensuring patients and families receive the specialized support they need—through prescription fulfillment, education, insurance assistance, and financial support for qualifying families. Together, we are empowering patients and caregivers with the resources and care they need to manage this rare disease.
Related Posts
Why Exclusivity Matters: Redefining Patient-Centricity in Rare and Ultra-Rare Drug Commercialization
In the rare disease space, every patient story is deeply personal, and every barrier to access feels monumental. From navigating…
June 4, 2025
The Heart of Our Success: How Our HR Team Fuels Growth & Culture
At Anovo, we know that our success starts with our people. Behind every dedicated team member, every seamless patient experience,…
May 19, 2025
Investing in Training to Elevate Patient Care
At Anovo, we believe that exceptional patient support starts with a well-trained, knowledgeable team. As we continue to grow, we’ve…
April 1, 2025
